LA ENFERMEDAD DE CROHN COMO RESULTADO DE LA DESREGULACIÓN DEL SISTEMA INMUNITARIO
DOI:
https://doi.org/10.47820/recima21.v3i8.1844Palabras clave:
''sistema inmunológico'', ''enfermedad de crohn''Resumen
Introducción: La enfermedad de Crohn (EC) es una enfermedad inflamatoria intestinal incurable en la que se produce inflamación y ulceración de la mucosa del tracto gastrointestinal. Los linfocitos del sistema inmunitario controlan el proceso inflamatorio provocando un aumento excesivo de citoquinas proinflamatorias. Objetivo: Analizar la influencia del sistema inmune en el origen y desarrollo de la EC. Materiales y Métodos: Se realizó una revisión bibliográfica integradora, con el objetivo de correlacionar el sistema inmune con la EC. Para el análisis de los datos, se incluyó un estudio clínico, un ensayo clínico, un estudio comparativo, un meta-análisis, un estudio multicéntrico, un estudio observacional y un ensayo controlado aleatorio. Para este estudio se utilizaron artículos de la base de datos Pubmed, publicados entre los años 2018 y 2022. Los descriptores elegidos fueron "crohn 's disease" y "immune system". Se excluyeron libros y documentos, revisiones y revisiones sistemáticas. Tras los criterios de inclusión y exclusión, se seleccionaron 28 artículos. Resultados: Las citocinas y quimiocinas liberadas por el aumento de neutrófilos aumentan la gravedad de la inflamación. En este proceso se expresarán la interleucina-1, la interleucina-6 y el factor de necrosis tumoral-α. Conclusión: El sistema inmune tiene una fuerte relación con la progresión de la EC a partir de un desequilibrio en la producción de células de defensa, desencadenando lesiones inmunológicas e infiltraciones prominentes de estas células.
Descargas
Citas
ALEXANDER, Katie L. et al. Human microbiota flagellins drive adaptive immune responses in Crohn’s disease. Gastroenterology, v. 161, n. 2, p. 522-535. e6, 2021.
ROSEN, Michael J. et al. Mucosal expression of type 2 and type 17 immune response genes distinguishes ulcerative colitis from colon-only Crohn’s disease in treatment-naive pediatric patients. Gastroenterology, v. 152, n. 6, p. 1345-1357. e7, 2017.
SINNIGER, Valerie et al. A 12‐month pilot study outcomes of vagus nerve stimulation in Crohn's disease. Neurogastroenterology & Motility, v. 32, n. 10, p. e13911, 2020.
GLOBIG, Anna-Maria et al. Ustekinumab inhibits T follicular helper cell differentiation in patients with Crohn’s disease. Cellular and Molecular Gastroenterology and Hepatology, v. 11, n. 1, p. 1-12, 2021.
HE, Liwen et al. Protective association of TNFSF15 polymorphisms with Crohn's disease and ulcerative colitis: A meta-analysis. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association, v. 24, n. 4, p. 201, 2018.
BOURGONJE, Arno R. et al. Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1-and Th17-associated cytokines. PLoS One, v. 13, n. 2, p. e0193202, 2018.
DA SILVA, Francesca Aparecida Ramos et al. Whole transcriptional analysis identifies markers of B, T and plasma cell signaling pathways in the mesenteric adipose tissue associated with Crohn’s disease. Journal of translational medicine, v. 18, n. 1, p. 1-14, 2020.
BAKOUNY, Z. et al. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in Crohn's disease: The controversy remains. Clinics and Research in Hepatology and Gastroenterology, v. 42, n. 1, p. e16-e18, 2017.
SEKIDO, Yuki et al. Some Gammaproteobacteria are enriched within CD14+ macrophages from intestinal lamina propria of Crohn’s disease patients versus mucus. Scientific reports, v. 10, n. 1, p. 1-8, 2020.
SNOWDEN, John A. et al. Autologous stem cell transplantation in refractory Crohn’s disease–low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study. BMC gastroenterology, v. 19, n. 1, p. 1-14, 2019.
VISVANATHAN, Sudha et al. Selective IL-23 inhibition by risankizumab modulates the molecular profile in the colon and ileum of patients with active Crohn’s disease: results from a randomised phase II biopsy sub-study. Journal of Crohn's and Colitis, v. 12, n. 10, p. 1170-1179, 2018.
FONSECA-CAMARILLO, Gabriela et al. Differential expression of IL-36 family members and IL-38 by immune and nonimmune cells in patients with active inflammatory bowel disease. BioMed research international, v. 2018, 2018.
CAO, Brent L. et al. Systematic review and meta-analysis on the association of tuberculosis in Crohn’s disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα). World journal of gastroenterology, v. 24, n. 25, p. 2764, 2018.
NADALIAN, Banafsheh et al. Prevalence of the pathobiont adherent‐invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta‐analysis. Journal of gastroenterology and hepatology, v. 36, n. 4, p. 852-863, 2021.
FU, Wei et al. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: A meta-analysis. International Immunopharmacology, v. 101, p. 108235, 2021.
KONDO, Ayano et al. Highly multiplexed image analysis of intestinal tissue sections in patients with inflammatory bowel disease. Gastroenterology, v. 161, n. 6, p. 1940-1952, 2021.
YAMAGUCHI, Natsu et al. The different roles of innate immune receptors in inflammation and carcinogenesis between races. Environmental Health and Preventive Medicine, v. 22, n. 1, p. 1-5, 2017.
COMECHE, Jose M. et al. Parenteral nutrition in patients with inflammatory bowel disease systematic review, meta-analysis and meta-regression. Nutrients, v. 11, n. 12, p. 2865, 2019.
ZIBANDEH, Noushin et al. Human dental follicle mesenchymal stem cells alleviate T cell response in inflamed tissue of Crohn’s patients. The Turkish Journal of Gastroenterology, v. 31, n. 5, p. 400, 2020.
MOTOYA, Satoshi et al. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study. BMC gastroenterology, v. 19, n. 1, p. 1-15, 2019.
AMERIKANOU, Charalampia et al. Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with mastiha. Biomedicine & Pharmacotherapy, v. 138, p. 111535, 2021.
COLETTA, Marina et al. Immunological variables associated with clinical and endoscopic response to vedolizumab in patients with inflammatory bowel diseases. Journal of Crohn's and Colitis, v. 14, n. 9, p. 1190-1201, 2020.
COOK, Laura et al. Analysis of flagellin-specific adaptive immunity reveals links to dysbiosis in patients with inflammatory bowel disease. Cellular and Molecular Gastroenterology and Hepatology, v. 9, n. 3, p. 485-506, 2020.
FABIAN, Ondrej et al. Immunohistochemical assessment of CD30+ lymphocytes in the intestinal mucosa facilitates diagnosis of pediatric ulcerative colitis. Digestive Diseases and Sciences, v. 63, n. 7, p. 1811-1818, 2018.
PAPOUTSOPOULOU, Stamatia et al. Macrophage-specific NF-κB activation dynamics can segregate inflammatory bowel disease patients. Frontiers in immunology, v. 10, p. 2168, 2019.
DAI, Shi-xue et al. Decreased CD8+ CD28+/CD8+ CD28–T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease. Medicine, v. 96, n. 26, 2017.
DAI, Shi-xue et al. CD8+ CD28+/CD8+ CD28− T cell equilibrium can predict the active stage for patients with inflammatory bowel disease. Clinics and Research in Hepatology and Gastroenterology, v. 41, n. 6, p. 693-702, 2017.
Descargas
Publicado
Cómo citar
Número
Sección
Categorías
Licencia
Derechos de autor 2022 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
Clique para ver detalhes 
